The human and financial cost of underdiagnosis in women's health
Women's health is too often treated as a narrow benefit category, defined by maternity and annual screenings. The result is a system in which underdiagnosis is the norm, not the exception. For every one woman diagnosed with a serious condition, several more remain undiagnosed across menopause, cardiovascular disease, hormonal disorders and cancer.
The downstream effect is measurable and growing. U.S. maternal mortality remains more than double that of peer nations, and Black women are approximately three times more likely than white women to die from pregnancy-related causes, according to the CDC.
Heart disease is the leading cause of death among women, yet its connection to hormonal transition is rarely addressed within traditional care models. Half of women report postponing care in the past year due to cost, access or prior negative experiences. The financial implications follow: McKinsey estimates U.S. health systems are leaving $50 billion in annual revenue on the table.
A recent Becker's Healthcare advisory call examined what it takes to close these gaps. Payer and provider leaders detailed how a lifecycle approach can improve outcomes while strengthening Star Ratings, HEDIS performance and long-term cost containment.
Inside the report:
The downstream effect is measurable and growing. U.S. maternal mortality remains more than double that of peer nations, and Black women are approximately three times more likely than white women to die from pregnancy-related causes, according to the CDC.
Heart disease is the leading cause of death among women, yet its connection to hormonal transition is rarely addressed within traditional care models. Half of women report postponing care in the past year due to cost, access or prior negative experiences. The financial implications follow: McKinsey estimates U.S. health systems are leaving $50 billion in annual revenue on the table.
A recent Becker's Healthcare advisory call examined what it takes to close these gaps. Payer and provider leaders detailed how a lifecycle approach can improve outcomes while strengthening Star Ratings, HEDIS performance and long-term cost containment.
Inside the report:
- Why a 1-star Medicare Advantage rating improvement can drive 8 to 12% enrollment growth
- How predictive analytics and longitudinal lab data are reshaping risk identification
- What flexible scheduling, community health workers and trauma-informed care contribute to engagement
Please fill out the form to download the e-Book.